SCHEMBL6415752

SCHEMBL6415752

N#Cc1cc(-c2ccc(Cl)cc2)oc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.43
HPGD P15428 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
MCL1 Q07820 1/20 0.41
ALDH1A1 P00352 5/20 0.40
GAA P10253 3/20 0.40
GLA P06280 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
BCHE P06276 1/20 0.40
NOTUM Q6P988 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18342012 0.83 ALDH1A1 (0.40) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL26104293 0.83 MAOB (0.41) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL1789380 0.82 MEN1 (0.50) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL4829289 0.79 KDM4E (0.51) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL5771594 0.76 TNKS (0.41) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL27854213 0.71 MAOA (0.40) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL5635202 0.71 CYP11B2 (0.45) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL3274518 0.69 MCL1 (0.51) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL18341896 0.69 ALDH1A1 (0.51) KDM4EHPGDMEN1KMT2AMAPT
SCHEMBL10555140 0.67 ALDH1A1 (0.44) KDM4EHPGDMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505772-B2 Aromatic ring compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-11-29 US disclosed
US-20150111894-A1 AROMATIC RING COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-04-23 US disclosed
EP-2848622-A1 AROMATIC RING COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-03-18 EP disclosed
WO-2005092896-A1 COMPOUND FOR INHIBITING TYROSINE KINASE ACTIVITY OF DDR2 PROTEIN KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111894-A1 AROMATIC RING COMPOUND MC1R, MC4R, TYR KDM4E 1302/4885HPGD 3149/4885MEN1 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.